No circulating human cytomegalovirus in 14 cases of glioblastoma.

作者: S. Lehrer , S. Green , K. E. Rosenzweig , A. Rendo

DOI: 10.1093/NEUONC/NOU325

关键词: ImmunologyRisk factorHuman cytomegalovirusIncidence (epidemiology)GlioblastomaSeroprevalencePoliomyelitisReverse transcriptaseCongenital cytomegalovirus infectionMedicine

摘要: Cobbs et al have reported that many gliomas contain human cytomegalovirus (HCMV) gene products.1 Mitchell 80% of patients with diagnosed glioblastoma multiforme HCMV DNA in their peripheral blood; seropositive normal donors and other surgical did not.2 However, Baumgarten infection tumor cells the nervous system is not detectable standardized pathologico-virological diagnostics,3 calling into question etiologic role glioblastoma.4 In our own studies, we collected blood anticoagulated tubes from 14 newly who were referred for radiation therapy.5 We used standard methods detecting by reverse transcriptase PCR6 culture.7 None had circulating detected. blood.2 The chance a single patient having would be 20% or 0.2. Therefore, none 0.214 P = 1.6 × 10−10. Moreover, seropositivity data incidence do support HCMV-glioblastoma association since seroprevalence rates are consistently related to rates.8 is, however, socioeconomic status. significantly lower whites than blacks Hispanics (Mexican Americans), while higher Hispanics. But women men, although more common men. possible cannot readily substantiated rates. Age at may involved both status, as described above. early childhood, which groups, protective against glioblastoma, whereas later childhood adulthood risk factor glioblastoma. If so, similar paralytic polio, low poor hygiene, protective.9

参考文章(9)
J Gozlan, J M Salord, C Chouaïd, C Duvivier, O Picard, M C Meyohas, J C Petit, Human cytomegalovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection. Journal of Clinical Microbiology. ,vol. 31, pp. 1943- 1945 ,(1993) , 10.1128/JCM.31.7.1943-1945.1993
D. Shibata, W. J. Martin, M. D. Appleman, D. M. Causey, J. M. Leedom, N. Arnheim, Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. The Journal of Infectious Diseases. ,vol. 158, pp. 1185- 1192 ,(1988) , 10.1093/INFDIS/158.6.1185
Duane A. Mitchell, Weihua Xie, Robert Schmittling, Chris Learn, Allan Friedman, Roger E. McLendon, John H. Sampson, Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma Neuro-oncology. ,vol. 10, pp. 10- 18 ,(2008) , 10.1215/15228517-2007-035
Peter Baumgarten, Martin Michaelis, Florian Rothweiler, Tatjana Starzetz, Holger F Rabenau, Annemarie Berger, Lukas Jennewein, Anne K Braczynski, Kea Franz, Volker Seifert, Joachim P Steinbach, Regina Allwinn, Michel Mittelbronn, Jindrich Cinatl, None, Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics Neuro-oncology. ,vol. 16, pp. 1469- 1477 ,(2014) , 10.1093/NEUONC/NOU167
Kenneth Rosenzweig, Lakshmi Ramanathan, Sheryl Green, Steven Lehrer, Vincent Labombardi, No consistent relationship of glioblastoma incidence and cytomegalovirus seropositivity in whites, blacks, and Hispanics. Anticancer Research. ,vol. 32, pp. 1113- 1115 ,(2012)
Isabelle M. Germano, Melissa S. Pessin-Minsley, Kenneth E. Rosenzweig, Sheryl Green, Steven Lehrer, Vincent Labombardi, No circulating cytomegalovirus in five patients with glioblastoma multiforme. Anticancer Research. ,vol. 31, pp. 959- 960 ,(2011)
J. T. Huse, K. Aldape, CMV and glioma–are we there yet? Neuro-oncology. ,vol. 16, pp. 1433- 1434 ,(2014) , 10.1093/NEUONC/NOU296